The biopharmaceutical industry is in the midst of a period of rapid growth. It is also experiencing increasing uncertainty, diversification of modalities, and cost pressure. The challenges associated with these market trends, which have accelerated in response to the Covid-19 pandemic, require a reconsideration of biologics manufacturing. To address these challenges, the industry will need to embrace the facility of the future – a new biomanufacturing paradigm.
This infographic identifies market trends challenging biopharmaceutical companies, business drivers to meet market needs, as well as requirements and aspirations for the factory of the future.
The original infographic was published 2/25/21 on Labiotech.eu